A Meeting Regarding the Therapeutic Potential of Antibodies for HIV
In 2009 Search was introduced to an interesting monoclonal antibody that had been used in a 188 patients in the early days of the disease before the antivirals existed that showed promissing evidence of viral reduction. The antibody is called Cytolin. Since then we have been following the progress of its development as it is now being researched by Dr. Eric Rosenberg at Massachusetts General Hospital. We conducted an interview with Dr. Rosenberg about its progress in October of 2011 which you can read under our Q&A section here. To our surprise in the last few years there has been an explosion of antibodies being approved as therapeutics for all kinds of illnesses, and there are now multiple promising ones in the lab with potential for the HIV population including Ibalizumab, Cytolin, and PRO140.
TRANSLATE
afrikaans
albanian
arabic
belarusian
bulgarian
catalan
chinese
chinese simplified
chinese traditional
croatian
czech
danish
dutch
english
estonian
finnish
french
galician
german
greek
hebrew
hindi
haitian creole
hungarian
icelandic
indonesian
irish
italian
japanese
korean
latvian
lithuanian
macedonian
malay
maltese
norwegian
persian
polish
portuguese
romanian
russian
serbian
slovak
slovenian
spanish
swahili
swedish
tagalog
thai
turkish
ukrainian
vietnamese
welsh
yiddish